Therapies for Uncontrolled Asthma

Download this white paper, which looks at novel biologics in development for the treatment of uncontrolled, eosinophilic asthma and whether they can fulfill the promise of truly targeted therapies for one of the most prevalent respiratory diseases worldwide.

Novel Biologics for Asthma: Steps on the Long Road to Therapies for Uncontrolled Asthma

Overview of sponsors, molecular targets and current status of novel biologics targeting IL-5, IL-4 or IL-13 with development programs for asthma
Program trials and status for IL-5 and Th2 pathway antagonists
Key study design features including inclusion criteria, biomarkers and primary endpoints
Outcomes for efficacy trials of targeted biologics in asthma
Why stratification of the uncontrolled asthma population by specific biomarker levels could be crucial to reduce exacerbation rates and more